Holen Sie sich die Stockscreener-App
1.345
1.10%
-0.015
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LXRX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.36
Offen:
$1.33
24-Stunden-Volumen:
948.37K
Relative Volume:
0.41
Marktkapitalisierung:
$488.77M
Einnahmen:
$1.21M
Nettoeinkommen (Verlust:
$-177.12M
KGV:
-1.6813
EPS:
-0.8
Netto-Cashflow:
$-162.37M
1W Leistung:
-1.82%
1M Leistung:
-4.61%
6M Leistung:
+97.62%
1J Leistung:
+11.62%
1-Tages-Spanne:
$1.3201
$1.39
1-Wochen-Bereich:
$1.3031
$1.40
52-Wochen-Spanne:
$0.2836
$1.66
Lexicon Pharmaceuticals Inc Stock (LXRX) Company Profile
Firmenname
Lexicon Pharmaceuticals Inc
Sektor
Branche
Telefon
(281) 863-3000
Adresse
2445 TECHNOLOGY FOREST BLVD., THE WOODLANDS
Vergleichen Sie LXRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LXRX
Lexicon Pharmaceuticals Inc
|
1.345 | 494.22M | 1.21M | -177.12M | -162.37M | -0.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.31 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.37 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.58 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
836.79 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.68 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lexicon Pharmaceuticals Inc Stock (LXRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-05 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-06-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-04-30 | Eingeleitet | Leerink Partners | Outperform |
| 2023-03-07 | Eingeleitet | Jefferies | Hold |
| 2022-08-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-01-29 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-01-29 | Herabstufung | Wedbush | Outperform → Neutral |
| 2020-12-08 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-11-18 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2019-12-11 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2019-11-08 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-09-11 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2019-07-29 | Herabstufung | Stifel | Buy → Hold |
| 2019-03-25 | Hochstufung | Gabelli & Co | Sell → Hold |
| 2018-07-31 | Bestätigt | Stifel | Buy |
| 2018-02-23 | Herabstufung | Needham | Buy → Hold |
| 2018-02-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-03-01 | Bestätigt | H.C. Wainwright | Buy |
| 2017-03-01 | Bestätigt | Wedbush | Outperform |
| 2016-10-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-08-05 | Bestätigt | Wedbush | Outperform |
| 2016-08-02 | Eingeleitet | Citigroup | Buy |
| 2016-03-02 | Bestätigt | Wedbush | Outperform |
| 2015-11-09 | Bestätigt | Wedbush | Outperform |
| 2015-09-28 | Hochstufung | Gabelli & Co | Sell → Hold |
| 2015-09-18 | Herabstufung | Gabelli & Co | Hold → Sell |
| 2015-08-10 | Herabstufung | JP Morgan | Overweight → Neutral |
Alle ansehen
Lexicon Pharmaceuticals Inc Aktie (LXRX) Neueste Nachrichten
Lexicon (NASDAQ: LXRX) to present sotagliflozin data in HFpEF, HCM, and T2D at AHA 2025 - Stock Titan
What MACD signals say about Lexicon Pharmaceuticals Inc.Earnings Overview Summary & Fast Momentum Stock Entry Tips - newser.com
What the charts say about Lexicon Pharmaceuticals Inc. today2025 Price Action Summary & Weekly Market Pulse Alerts - newser.com
Applying Wyckoff theory to Lexicon Pharmaceuticals Inc. stockGlobal Markets & Free Reliable Trade Execution Plans - newser.com
Why Lexicon Pharmaceuticals Inc. stock remains a top recommendation2025 Top Gainers & Daily Chart Pattern Signal Reports - newser.com
Is Lexicon Pharmaceuticals Inc. stock attractive for growth ETFsJuly 2025 Setups & Accurate Trade Setup Notifications - newser.com
Published on: 2025-11-02 14:31:16 - newser.com
What candlestick patterns are forming on Lexicon Pharmaceuticals Inc.2025 Big Picture & Safe Entry Zone Identification - newser.com
Using data tools to time your Lexicon Pharmaceuticals Inc. exitQuarterly Market Review & Real-Time Sentiment Analysis - newser.com
Is Lexicon Pharmaceuticals Inc. stock attractive for hedge fundsQuarterly Growth Report & Verified Trade Idea Suggestions - newser.com
Published on: 2025-10-31 04:02:24 - newser.com
Lexicon Pharmaceuticals, Inc. (LXRX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Lexicon Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025 - The Manila Times
Lexicon (NASDAQ: LXRX) sets Nov. 6 call for third quarter results at 8:30 a.m. ET - Stock Titan
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2024 Earnings Call Transcript - MSN
How analysts rate Lexicon Pharmaceuticals Inc. stock todayLayoff News & Free Real-Time Volume Trigger Notifications - Fundação Cultural do Pará
Is Lexicon Pharmaceuticals Inc. stock a defensive play in 2025Weekly Earnings Recap & Free Accurate Trade Setup Notifications - fcp.pa.gov.br
Weiss Ratings Reaffirms "Sell (D-)" Rating for Lexicon Pharmaceuticals (NASDAQ:LXRX) - MarketBeat
Finanzdaten der Lexicon Pharmaceuticals Inc-Aktie (LXRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):